Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia, Myeloid, Acute × Control Groups × Clear all

Phase

Status

Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 8 Stomach Neoplasms 3 Neoplasms 3 Pain 2 Motor Activity 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Fatigue 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Psychological Well-Being 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Lymphoma 1 Lymphedema 1 Lymphatic Metastasis 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Incisional Hernia 1 Hernia, Abdominal 1 Heart Failure 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Cytarabine 53 Decitabine 30 Azacitidine 28 Idarubicin 21 venetoclax 19 fludarabine 13 Cyclophosphamide 12 Granulocyte Colony-Stimulating Factor 11 Daunorubicin 10 Busulfan 9 Mitoxantrone 8 Homoharringtonine 7 Etoposide 7 Cladribine 7 Aclarubicin 7 fludarabine phosphate 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 5 Filgrastim 5 Cyclosporine 5 aclacinomycins 4 Tretinoin 4 Sorafenib 4 Radiotherapy 4 Polymerase Chain Reaction 4 Lenalidomide 4 Gemtuzumab 4 Clofarabine 4 Arsenic Trioxide 4 quizartinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04240600 2020-09-03

HEMVEF

Hospital General de Mexico

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡